Neurocrine Biosciences Inc
(FRA:NB3)
€
125.5
-0.55 (-0.44%)
Market Cap: 12.26 Bil
Enterprise Value: 11.61 Bil
PE Ratio: 36.05
PB Ratio: 5.52
GF Score: 94/100 - Q1 2024 Neurocrine Biosciences Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 07, 2024€133.55 (+1.06%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Neurocrine Biosciences Inc To Host Analyst Day TranscriptDec 05, 2023
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Neurocrine Biosciences Inc Earnings Call TranscriptOct 31, 2023Earnings
- Neurocrine Biosciences Inc To Report Crinecerfont PhIII Congenital Adrenal Hyperplasia Results TranscriptOct 05, 2023
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Neurocrine Biosciences Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Neurocrine Biosciences Inc Earnings Call TranscriptAug 01, 2023€91.96 (-0.73%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Neurocrine Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Neurocrine Biosciences Inc Earnings Call TranscriptMay 03, 2023€92.2 (-3.35%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Neurocrine Biosciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 06, 2023€97.48 (-0.04%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call TranscriptJan 09, 2023
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2022€115.86 (+2.13%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Neurocrine Biosciences Inc Earnings Call TranscriptAug 04, 2022€91.77 (+1.16%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Neurocrine Biosciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Neurocrine Biosciences Inc Earnings Call TranscriptMay 04, 2022€83.83 (-2.92%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Needham Neuroscience Forum (Virtual) TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 11, 2022€68.42 (-2.92%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2021€90.78 (+4.20%)Earnings
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2021€80.44 (+2.63%)Earnings
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Neurocrine Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Neurocrine Biosciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Neurocrine Biosciences Inc Earnings Call TranscriptMay 05, 2021€75.8 (+0.21%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Day TranscriptApr 01, 2021
- Neurocrine Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Neurocrine Biosciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2021€93.08 (-0.68%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat TranscriptNov 23, 2020
- Neurocrine Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Neurocrine Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 Neurocrine Biosciences Inc Earnings Call TranscriptNov 09, 2020€83.2 (-0.07%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Neurocrine Biosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptAug 06, 2020
- Q2 2020 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2020€104.15 (+2.97%)Earnings
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 22, 2020
- Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders TranscriptJun 16, 2020
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Neurocrine Biosciences Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Neurocrine Biosciences Inc Earnings Call TranscriptMay 06, 2020€93.68 (+3.15%)Earnings
- Neurocrine Biosciences Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2020€91.14 (+0.91%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Neurocrine Biosciences Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 20, 2019
- Neurocrine Biosciences Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Neurocrine Biosciences Inc Earnings Call TranscriptNov 04, 2019€94.86 (+6.92%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 Neurocrine Biosciences Inc Earnings Call TranscriptJul 29, 2019€77.7 (+2.37%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 06, 2019
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Neurocrine Biosciences Inc Earnings Call TranscriptApr 29, 2019€68.7 (-0.23%)Earnings
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Neurocrine Biosciences Inc at Cowen Health Care Conference TranscriptMar 12, 2019
Neurocrine Biosciences Inc at Barclays Global Healthcare Conference Transcript
Mar 13, 2019 / 03:15PM GMT
Release Date Price:
€70.84
(-1.30%)
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst
Okay, welcome to the second day of the Barclays Global Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here. And Scott Gaffner from my team is up with me on stage too. And we're thrilled to have Neurocrine Biosciences here. And on my right here is CEO, Kevin Gorman; and CFO, Matt Abernethy. Welcome, guys.
Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director
Thank you.
Matthew C. Abernethy
Neurocrine Biosciences, Inc. - CFO
Thank you.
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst
So a lot of stuff to talk about, but maybe the most topical was the CAH data just coming out yesterday. I just want to kind of get you guys' view. Obviously, the adult data is sort of the segue into the ultimate pediatric population. But maybe kind of give us your high level. We'll get to some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)